Martin Scheffner
Impact in
- Oncology top 0.1%
- Cancer-related Molecular Pathways
- Molecular Biology top 0.2%
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Protein Degradation and Inhibitors
Papers in
- Oncology 75
- Cancer-related Molecular Pathways 51
- Peptidase Inhibition and Analysis 19
-
- Ubiquitin and proteasome pathways 76
- Protein Degradation and Inhibitors 16
- Epigenetics and DNA Methylation 13
- Cancer-related gene regulation 11
- Co-authors
- Peter M. Howley (18 shared papers)Jon M. Huibregtse (14 shared papers)Arnold J. Levine (1 shared paper)Bruce A. Werness (1 shared paper)Richard David Vierstra (1 shared paper)Ulrike A. Nuber (6 shared papers)Karl Münger (5 shared papers)Arnd Hengstermann (8 shared papers)
- Journals
- Journal of Biological Chemistry (13 papers)Proceedings of the National Academy of Sciences (12 papers)Molecular and Cellular Biology (8 papers)ChemBioChem (8 papers)Nature Communications (6 papers)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Martin Scheffner
139 papers receiving 18.8k citations
Martin Scheffner's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 7.7k
- Molecular Biology 12.7k
- Epidemiology 5.0k
- Cancer Research 1.9k
- Genetics 3.5k
Countries citing papers authored by Martin Scheffner
This map shows the geographic impact of Martin Scheffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Scheffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Scheffner more than expected).
Fields of papers citing papers by Martin Scheffner
This network shows the impact of papers produced by Martin Scheffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Scheffner. The network helps show where Martin Scheffner may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Scheffner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Hit paper breakdown → | 1990 | 3454 |
| 2 | The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Hit paper breakdown → | 1993 | 2039 |
| 3 | A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Hit paper breakdown → | 1995 | 840 |
| 4 | Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade Hit paper breakdown → | 1995 | 832 |
| 5 | The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Hit paper breakdown → | 1991 | 756 |
| 6 | A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. Hit paper breakdown → | 1991 | 744 |
| 7 | 2002 | 709 | |
| 8 | 1993 | 462 | |
| 9 | 1999 | 435 | |
| 10 | 1993 | 330 | |
| 11 | 2005 | 321 | |
| 12 | 1998 | 307 | |
| 13 | 2003 | 288 | |
| 14 | 2003 | 288 | |
| 15 | 1989 | 283 | |
| 16 | 1999 | 282 | |
| 17 | Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. | 1992 | 238 |
| 18 | 1994 | 235 | |
| 19 | 2013 | 234 | |
| 20 | 2005 | 227 |
About Martin Scheffner
Martin Scheffner is a scholar working on Oncology, Molecular Biology, Genetics, Epidemiology and Biotechnology, having authored 143 papers that have together received 19.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (76 papers), Cancer-related Molecular Pathways (51 papers), Peptidase Inhibition and Analysis (19 papers), Cervical Cancer and HPV Research (17 papers), Virus-based gene therapy research (17 papers), Protein Degradation and Inhibitors (16 papers), Epigenetics and DNA Methylation (13 papers) and Cancer-related gene regulation (11 papers). The work is most often cited by research in Oncology (7.7k citations), Molecular Biology (12.7k citations), Epidemiology (5.0k citations), Cancer Research (1.9k citations) and Genetics (3.5k citations). Martin Scheffner has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Peter M. Howley, Jon M. Huibregtse, Arnold J. Levine, Bruce A. Werness, Richard David Vierstra, Ulrike A. Nuber, Karl Münger, Arnd Hengstermann, Sylvie L. Beaudenon and Sylvia E. Schwarz. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, ChemBioChem and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.